Farallon Capital Partners, L.P. 13D/13G Filings for Chinook Therapeutics, Inc. (KDNY)

Farallon Capital Partners, L.P. 13D and 13G filings for Chinook Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-08-11
5:17 pm
Purchase
2023-08-02 13D Chinook Therapeutics, Inc.
KDNY
Farallon Capital Partners, L.P. 7,110,000
9.900%
7,110,000increase
(New Position)
Filing